Table 2

Baseline sleep and cardiometabolic parameters of the ITT population

VariablesERGO (n=18)ERGO+RMT (n=18)ERGO+NIV (n=17)
Mean CPAP use (hour)6.7 (6.0; 7.7)7.5 (6.4; 8.1)6.7 (6.0; 7.4)
AHI (events/hour of sleep)2.8 (2.4; 3.3)2.2 (1.8; 3.6)2.3 (1.8; 2.6)
Mean nocturnal SpO2 (%)95.3 (94.0; 96.5)95.9 (94.8; 96.5)95.0 (93.5; 95.5)
Epworth sleepiness score8.0 (6.0; 10.5)7.5 (5.5; 11.0)7.5 (5.5; 9.0)
Self-measured blood pressure
  Systolic BP (mm Hg)130. (125.0; 134.5)130.5 (121.5; 134.0)135.0 (126.5; 143.5)
  Diastolic BP (mm Hg)76.5 (74.0; 83.0)78.8 (66.5; 85.5)82.0 (77.5; 85.5)
  Heart rate (beat/min)65.5 (58.5; 71.5)66.5 (60.0; 71.5)68.0 (66.0; 75.0)
PWV (m/s)9.5 (8.2; 10.8)9.5 (9.2; 10.1)10.9 (9.1; 12.4)
RH-PAT0.6 (0.4; 0.7)0.5 (0.4; 0.8)0.5 (0.3; 0.6)
Metabolic and inflammatory biomarkers
  Total cholesterol (g/L)1.9 (1.4; 2.1)1.7 (1.6; 2.1)2.0 (1.7; 2.1)
  LDL/HDL cholesterol ratio3.8 (3.5; 4.5)4.2 (3.5; 5.3)4.4 (3.9; 5.0)
  Triglycerides (g/L)1.4 (1.2; 1.9)1.4 (1.1; 1.7)1.4 (1.0; 1.7)
  Glucose (mmol/L)5.4 (5.1; 6.6)6.1 (5.5; 8.1)5.7 (5.5; 6.4)
  Insulin (µUI/mL)17.5 (13.7; 24.4)20.4 (15.2; 29.3)17.7 (9.7; 27.5)
  HOMA index4.1 (3.2; 9.8)5.3 (3.7; 10.4)4.5 (2.5; 6.9)
  Free fatty acids (mmol/L)63 (426; 702)495 (417; 626)488 (421; 605)
  hsCRP (mg/L)3.4 (2.1; 6.7)3.9 (2.5; 8.5)3.2 (2.0; 4.0)
  • Data are median (IQR) or number (%).

  • AHI, apnoea hypopnea index; CPAP, continuous positive airway pressure; DBP, diastolic blood pressure; ERGO, ergocycle training; HOMA, homeostasis model assessment=insulinaemia (mU/L)×glycaemia (mmol/L)/22.5; HR, heart rate; hsCRP, high sensitive C-reactive protein; ITT, intention to treat; LDL/HDL, low density lipid to high density lipids ratio; NIV, non-invasive ventilation; PWV, pulse wave velocity; RH-PAT, reactive hyperaemia peripheral arterial tonometry; RMT, respiratory muscle training; SaO2, oxygen saturation; SBP, systolic blood pressure; 6MWD, 6 min walking distance.